Cite
HARVARD Citation
Böttcher, M. et al. (n.d.). First‐in‐man–proof of concept study with molidustat: a novel selective oral HIF‐prolyl hydroxylase inhibitor for the treatment of renal anaemia. British journal of clinical pharmacology. pp. 1557-1565. [Online].